papillary thyroid cancer

GPTKB entity

Statements (54)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 6
gptkbp:bfsParent gptkb:differentiated_thyroid_cancer
gptkb:selpercatinib
gptkb:medullary_thyroid_cancer
gptkbp:age young adults
adults
gptkbp:can_metastasize_to lungs
bones
lymph nodes
gptkbp:clinical_trial investigating genetic factors
testing combination therapies
ongoing studies for new treatments
gptkbp:current_use thyroiditis
multinodular goiter
gptkbp:end_of_life high 5-year survival rate
gptkbp:events imaging studies
regular monitoring
thyroid function tests
gptkbp:genetic_diversity BRAF mutation
RET/ PTC rearrangement
https://www.w3.org/2000/01/rdf-schema#label papillary thyroid cancer
gptkbp:location thyroid gland
gptkbp:occurs_in most common type of thyroid cancer
gptkbp:provides_information_on American Thyroid Association guidelines
National Comprehensive Cancer Network guidelines
gptkbp:public_awareness increased awareness campaigns
screening recommendations discussed
symptom recognition emphasized
gptkbp:research_focus gptkb:vaccine
biomarkers
targeted therapies
gptkbp:risk_factor radiation exposure
family history
female gender
gptkbp:scholarships educational resources provided
counseling services offered
support groups available
gptkbp:scientific_classification M0, M1 distant metastasis
N1, N2 lymph node involvement
T1, T2, T3, T4 stages
gptkbp:social_responsibility ultrasound
generally favorable
fine needle aspiration biopsy
common in iodine-sufficient areas
higher rates in women
increasing incidence in recent years
gptkbp:symptoms difficulty swallowing
hoarseness
neck swelling
gptkbp:treatment gptkb:hospital
radioactive iodine therapy
thyroid hormone therapy
gptkbp:type malignant neoplasm